Ripple effect: the SEC’s major questions doctrine problem by M. Donovan

Subjects: Get full text

Elon Musk Wants to Buy Twitter to Create a Free Speech Utopia: Now What? by Jacob van de Kerkhof

“…In his letter of intention submitted to the U.S. Securities and Exchange Commission, Musk describes that free speech is necessary in a democratic society, and he wishes to unlock its full potential by bringing Twitter under (his) private ownership. …”
Get full text

Should crypto assets be regarded as securities? Implications and findings by Radu BORES, Ana-Maria BORES

“…The U.S. Securities and Exchange Commission (SEC) has taken a proactive stance in asserting its authority over the crypto economy. …”
Get full text

Motivations and consequences of U.S. IPOs by Chinese firms by Oh, Bing Quan, Phung, Ngan Ha, Nguyen, Ngoc Linh

“…-listed Chinese companies (ULCC) find themselves once again in the crosshairs of the U.S. Securities and Exchange Commission. We examine the motivations and consequences of U.S. …”
Get full text

Earnings management : background, criticisms and answers / Hamid Pourjalali, Takiah Mohd. Iskandar and Aini Aman by Pourjalali, Hamid, Mohd. Iskandar, Takiah, Aman, Aini

“…In a series of speeches to the financial community during 1998, U.S. Securities and Exchange Commission's former Chairman Arthur Levitt, declared war on "improper earnings management, big bath restructuring charges, and cookie-jar reserves". …”
Get full text

Security breaches and modifications on cybersecurity disclosures by Jacob Peng, Chang-Wei Li

“…Motivation: Because of growing cybersecurity threats in recent years, the U.S. Securities and Exchange Commission (SEC) has issued several regulations and guidance that emphasized on the disclosure of material information on cybersecurity. …”
Get full text

Case study on accounting fraud of U.S.-listed Chinese companies by An, Tingting

Get full text

Computational integration and meta-analysis of abandoned cardio-(vascular/renal/metabolic) therapeutics discontinued during clinical trials from 2011 to 2022 by Carisa Zeng, Yoon Seo Lee, Austin Szatrowski, Deniel Mero, Bohdan B. Khomtchouk, Bohdan B. Khomtchouk, Bohdan B. Khomtchouk

“…In this study, we have harmonized and integrated information on all relevant CVRM drug assets from U.S. Securities and Exchange Commission (SEC) filings, clinical trial records, PharmGKB, Open Targets, and other platforms. …”
Get full text

Corporate real estate occupancy costs and its correlation to company performance by Choy, Chee San Sandra

Get full text